Inhibition of microRNA-155 regulates gastric mucosal barrier repair and inflammation by targeting SOCS1 for the treatment of acute gastritis

抑制microRNA-155可通过靶向SOCS1调节胃黏膜屏障修复和炎症,从而治疗急性胃炎。

阅读:2

Abstract

Acute gastritis is a common gastrointestinal disorder characterized by rapid onset of mucosal injury and infiltration of inflammatory cells, often induced by chemical irritants such as ethanol. Although inflammation is essential for mucosal defense and repair, excessive immune responses can lead to tissue damage and impaired healing. MicroRNAs (miRNAs), particularly those involved in immune regulation, have emerged as important modulators in various inflammatory conditions. However, their specific roles in the early phase of acute gastric inflammation remain unclear, and the mechanisms by which they influence mucosal damage are still not fully understood. In this study, we investigated the expression and functional significance of microRNA-155 (miR-155) in a mouse model of ethanol-induced acute gastritis. Our results showed that miR-155 expression was significantly upregulated in gastric mucosa following ethanol exposure, concomitant with elevated levels of pro-inflammatory cytokines including TNF-α and IL-6. Histological examination revealed that inhibition of miR-155 using a specific antagomir reduced inflammatory cell infiltration and attenuated mucosal injury. These findings suggest that miR-155 contributes to the exacerbation of acute gastric inflammation by promoting cytokine expression and epithelial damage. Importantly, this study highlights the role of miR-155 as an early-response regulator during acute gastric injury. Targeting miR-155 may offer a novel therapeutic strategy for the prevention or treatment of acute gastric mucosal damage. Furthermore, our findings provide a foundation for future exploration of miRNA-based interventions in inflammation-related gastrointestinal diseases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。